Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.

Damm F, Itzykson R, Kosmider O, Droin N, Renneville A, Chesnais V, Gelsi-Boyer V, de Botton S, Vey N, Preudhomme C, Clavert A, Delabesse E, Park S, Birnbaum D, Fontenay M, Bernard OA, Solary E.

Leukemia. 2013 Jun;27(6):1401-3. doi: 10.1038/leu.2013.35. No abstract available.

PMID:
23443343
2.

SETBP1 mutations in juvenile myelomonocytic leukaemia and myelodysplastic syndrome but not in paediatric acute myeloid leukaemia.

Shiba N, Ohki K, Park MJ, Sotomatsu M, Kudo K, Ito E, Sako M, Arakawa H, Hayashi Y.

Br J Haematol. 2014 Jan;164(1):156-9. doi: 10.1111/bjh.12595. No abstract available.

PMID:
24117422
3.

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.

Fernandez-Mercado M, Pellagatti A, Di Genua C, Larrayoz MJ, Winkelmann N, Aranaz P, Burns A, Schuh A, Calasanz MJ, Cross NC, Boultwood J.

Br J Haematol. 2013 Oct;163(2):235-9. doi: 10.1111/bjh.12491.

PMID:
23889083
4.

SETBP1 mutation analysis in 944 patients with MDS and AML.

Thol F, Suchanek KJ, Koenecke C, Stadler M, Platzbecker U, Thiede C, Schroeder T, Kobbe G, Kade S, Löffeld P, Banihosseini S, Bug G, Ottmann O, Hofmann WK, Krauter J, Kröger N, Ganser A, Heuser M.

Leukemia. 2013 Oct;27(10):2072-5. doi: 10.1038/leu.2013.145. No abstract available.

PMID:
23648668
5.

A meta-analysis of TET2 mutations shows a distinct distribution pattern in de novo acute myeloid leukemia and chronic myelomonocytic leukemia.

Euba B, Vizmanos JL, García-Granero M, Aranaz P, Hurtado C, Migueliz I, Novo FJ, García-Delgado M.

Leuk Lymphoma. 2012 Jun;53(6):1230-3. doi: 10.3109/10428194.2011.639878. No abstract available.

PMID:
22080757
6.

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.

Boultwood J, Perry J, Pellagatti A, Fernandez-Mercado M, Fernandez-Santamaria C, Calasanz MJ, Larrayoz MJ, Garcia-Delgado M, Giagounidis A, Malcovati L, Della Porta MG, Jädersten M, Killick S, Hellström-Lindberg E, Cazzola M, Wainscoat JS.

Leukemia. 2010 May;24(5):1062-5. doi: 10.1038/leu.2010.20. No abstract available.

PMID:
20182461
7.

Expression of the interleukin 6 gene in acute myeloid leukemia and myelodysplastic syndromes: a report on 49 cases.

Collyn d'Hooghe M, Fenaux P, Lantoine D, Loucheux-Lefebvre M, Kerckaert JP.

Nouv Rev Fr Hematol. 1990;32(3):175-7.

PMID:
2216700
8.

SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms.

Fabiani E, Falconi G, Fianchi L, Criscuolo M, Leone G, Voso MT.

Haematologica. 2014 Sep;99(9):e152-3. doi: 10.3324/haematol.2014.108159. No abstract available.

9.
10.

Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts.

Gelsi-Boyer V, Cervera N, Bertucci F, Brecqueville M, Finetti P, Murati A, Arnoulet C, Mozziconacci MJ, Mills KI, Cross NC, Vey N, Birnbaum D.

Haematologica. 2013 Apr;98(4):576-83. doi: 10.3324/haematol.2012.071506.

11.

Mutational analysis of RNA splicing machinery components in 206 children with myeloid malignancies.

Sakaguchi H, Makishima H, Muramatsu H, Visconte V, Jerez A, Jankowska AM, Tiu RV, Maciejewski JP, Kojima S.

Leuk Res. 2012 Dec;36(12):e215-7. doi: 10.1016/j.leukres.2012.06.002. No abstract available.

12.

Mutations in ras genes in myelocytic leukemias and myelodysplastic syndromes.

Bartram CR.

Blood Cells. 1988;14(2-3):533-8. Review.

PMID:
3067784
13.

C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders.

Caudill JS, Sternberg AJ, Li CY, Tefferi A, Lasho TL, Steensma DP.

Br J Haematol. 2006 Jun;133(6):638-41.

PMID:
16704439
14.

SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS.

Inoue D, Kitaura J, Matsui H, Hou HA, Chou WC, Nagamachi A, Kawabata KC, Togami K, Nagase R, Horikawa S, Saika M, Micol JB, Hayashi Y, Harada Y, Harada H, Inaba T, Tien HF, Abdel-Wahab O, Kitamura T.

Leukemia. 2015 Apr;29(4):847-57. doi: 10.1038/leu.2014.301.

15.
16.

NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype.

Zhang Y, Zhang M, Yang L, Xiao Z.

Leuk Res. 2007 Jan;31(1):109-11.

PMID:
16678898
17.

Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia.

Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, Hählen K, Hasle H, Licht JD, Gelb BD.

Nat Genet. 2003 Jun;34(2):148-50.

PMID:
12717436
18.

SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML.

Laborde RR, Patnaik MM, Lasho TL, Finke CM, Hanson CA, Knudson RA, Ketterling RP, Pardanani A, Tefferi A.

Leukemia. 2013 Oct;27(10):2100-2. doi: 10.1038/leu.2013.97. No abstract available.

19.

Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.

Bacher U, Haferlach C, Alpermann T, Kern W, Schnittger S, Haferlach T.

Haematologica. 2011 Sep;96(9):1284-92. doi: 10.3324/haematol.2011.043687.

20.

[Role of ASXL1 mutation in myeloid malignancies].

Sheng MY, Zhou Y, Xu MJ, Yang FC.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Aug;22(4):1183-7. doi: 10.7534/j.issn.1009-2137.2014.04.057. Review. Chinese.

PMID:
25130853

Supplemental Content

Support Center